AVHI

A V Homes, Inc.

AVHI

Delisted

AVHI was delisted on the 1st of October, 2018.

Back to rankings

Financial journalist opinion

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Achari Ventures Holdings Corp. (OTC: AVHI ), relating to its proposed merger/business combination with Vaso Corporation, as to whether the merger is fair to Achari Ventures stockholders.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

NEW YORK , July 22, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Achari Ventures Holdings Corp. (OTC: AVHI ), relating to its proposed merger/business combination with Vaso Corporation, as to whether the merger is fair to Achari Ventures stockholders.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. – AVHI

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Achari Ventures Holdings Corp . ( OTC : AVHI ) , relating to its proposed merger/business combination with Vaso Corporation, as to whether the merger is fair to Achari Ventures stockholders.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. – AVHI

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

NEW YORK , July 15, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Achari Ventures Holdings Corp. (OTC: AVHI), relating to its proposed merger/business combination with Vaso Corporation, as to whether the merger is fair to Achari Ventures stockholders.

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Achari Ventures Holdings Corp. - AVHI

Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger

Business Combination with Achari Ventures Holdings Corp. I is Expected to Be Completed in First Quarter of 2024 Merger with Achari Ventures Holdings Corp. I (NASDAQ:AVHI) expected to improve capital market access for existing and prospective investors of Vaso Corporation (OTCQX:VASO). The transaction values Vaso at a pro forma equity value of approximately $176 million at $10 per share.

Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger

Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger

Business Combination with Achari Ventures Holdings Corp. I is Expected to Be Completed in First Quarter of 2024 Merger with Achari Ventures Holdings Corp. I (NASDAQ:AVHI) expected to improve capital market access for existing and prospective investors of Vaso Corporation (OTCQX:VASO). The transaction values Vaso at a pro forma equity value of approximately $176 million at $10 per share.

Vaso Corporation, a Diversified Medical Technology Company Currently Trading on the OTCQX Market, to List on Nasdaq via SPAC Merger

See News Rankings

Charts implemented using Lightweight Charts™